The novel therapy of the medication represents a exciting development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide512300.izrablog.com/42434221/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment